Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APLNR | P35414 | 11/20 | 0.53 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.42 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.35 |
| ▸ | TUBB | P07437 | 1/20 | 0.35 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.35 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.35 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.35 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.35 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.35 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.35 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.35 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.35 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.35 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.35 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.35 |
| ▸ | TUBB2B | Q9BVA1 | 1/20 | 0.35 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.35 |
| ▸ | NNMT | P40261 | 2/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31472465 | 1.00 | APLNR (0.53) | APLNRSIRT6TUBB4ATUBBTUBA3C | |
| SCHEMBL20207483 | 0.83 | APLNR (0.50) | APLNRSIRT6TUBB4ATUBBTUBA3C | |
| SCHEMBL19965678 | 0.83 | APLNR (0.50) | APLNRSIRT6TUBB4ATUBBTUBA3C | |
| SCHEMBL24920783 | 0.83 | APLNR (0.58) | APLNRSIRT6TUBB4ATUBBTUBA3C | |
| SCHEMBL15157218 | 0.83 | APLNR (0.54) | APLNRSIRT6TUBB4ATUBBTUBA3C | |
| SCHEMBL21097069 | 0.80 | ALDH1A1 (0.39) | APLNR | |
| SCHEMBL5950443 | 0.80 | NOS3 (0.33) | APLNR | |
| SCHEMBL3138241 | 0.80 | SIRT6 (0.56) | APLNRSIRT6TUBB4ATUBBTUBA3C | |
| SCHEMBL19551084 | 0.79 | APLNR (0.47) | APLNRSIRT6TUBB4ATUBBTUBA3C | |
| SCHEMBL9885039 | 0.79 | APLNR (0.47) | APLNRSIRT6TUBB4ATUBBTUBA3C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 188 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3353272-A1 | PERFUME COMPOSITIONS | Givaudan SA (CH) | 2018-08-01 | — | — | EP | claimed |
| US-20180187123-A1 | Perfume Compositions | GIVAUDAN S.A. (CH) | 2018-07-05 | — | — | US | claimed |
| CN-108138081-A | Spice composition | 奇华顿股份有限公司 | 2018-06-08 | — | — | CN | claimed |
| WO-2017050971-A1 | PERFUME COMPOSITIONS | GIVAUDAN SA (CH) | 2017-03-30 | — | — | WO | claimed |
| CN-119549075-A | Perfume microcapsule for heating non-combustible cigarettes and preparation method and application thereof | 山东中烟工业有限责任公司 | 2025-03-04 | — | — | CN | disclosed |
| WO-2024151833-A1 | SPIRO DERIVATIVES AS M4 ACTIVATORS/MODULATORS AND USES THEREOF | CEREVEL THERAPEUTICS, LLC (US) | 2024-07-18 | — | — | WO | disclosed |
| WO-2024141757-A1 | LSD1 MODULATORS | EXSCIENTIA AI LIMITED (GB) | 2024-07-04 | — | — | WO | disclosed |
| US-20240209000-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS | INTELLIKINE LLC | 2024-06-27 | — | — | US | disclosed |
| US-20240209000-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS | INTELLIKINE LLC | 2024-06-27 | — | — | US | disclosed |
| US-11820766-B2 | Monoacylglycerol lipase modulators | JANSSEN PHARMACEUTICA NV (BE) | 2023-11-21 | — | — | US | disclosed |
| US-20230364097-A1 | TREATMENT OF CANCERS USING PI3 KINASE ISOFORM MODULATORS | INFINITY PHARMACEUTICALS, INC. (US) | 2023-11-16 | — | — | US | disclosed |
| US-20230364097-A1 | TREATMENT OF CANCERS USING PI3 KINASE ISOFORM MODULATORS | INFINITY PHARMACEUTICALS, INC. (US) | 2023-11-16 | — | — | US | disclosed |
| EP-1781239-A2 | COMPOSITIONS EFFECTIVE IN ALTERING THE PERCEPTION OF MALODOR | Patus Ltd (IL) | 2007-05-09 | — | — | EP | disclosed |
| US-20070065394-A1 | Compositions effective in altering the perception of malodor | PATUS LTD. (IL) | 2007-03-22 | — | — | US | disclosed |
| US-7192913-B2 | Enhancing the fragrance of an article | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2007-03-20 | — | — | US | disclosed |
| WO-2005046632-A9 | COMPOSITIONS EFFECTIVE IN ALTERING THE PERCEPTION OF MALODOR | PATUS LTD (IL) | 2005-09-22 | — | — | WO | disclosed |
| US-20050176009-A1 | Nucleotide sequences coding orphan receptors for identifying modulators of smell reception; enhancing odor detection; perfumes | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2005-08-11 | — | — | US | disclosed |
| WO-2005046632-A2 | COMPOSITIONS EFFECTIVE IN ALTERING THE PERCEPTION OF MALODOR | PATUS LTD. (IL) | 2005-05-26 | — | — | WO | disclosed |
| WO-2004071194-A2 | ENHANCING THE FRAGRANCE OF AN ARTICLE | UNIVERSITY OF FLORIDA (US) | 2004-08-26 | — | — | WO | disclosed |
| WO-2003091388-A2 | POLYMORPHIC OLFACTORY RECEPTOR GENES AND ARRAYS, KITS AND METHODS UTILIZING THEM | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2003-11-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240209000-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS | PIK3CA, PIK3CG, PIK3CD | APLNR 4207/4885SIRT6 3353/4885TUBB4A 2894/4885 |
| US-20230364097-A1 | TREATMENT OF CANCERS USING PI3 KINASE ISOFORM MODULATORS | PIK3CA, MCL1, PIK3CB | APLNR 2371/4885SIRT6 2772/4885TUBB4A 2922/4885 |
| US-11820766-B2 | Monoacylglycerol lipase modulators | MGLL, LPL, PNLIP | APLNR 2190/4885SIRT6 2439/4885TUBB4A 3047/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.